Lumos Diagnostics Holdings (ASX:LDX) Accounts Payable & Accrued Expense : A$3.06 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Lumos Diagnostics Holdings Accounts Payable & Accrued Expense?

Lumos Diagnostics Holdings's quarterly accounts payable & accrued expense declined from Dec. 2022 (A$6.11 Mil) to Jun. 2023 (A$4.29 Mil) and declined from Jun. 2023 (A$4.29 Mil) to Dec. 2023 (A$3.06 Mil).

Lumos Diagnostics Holdings's annual accounts payable & accrued expense increased from . 20 (A$0.00 Mil) to Jun. 2022 (A$5.86 Mil) but then declined from Jun. 2022 (A$5.86 Mil) to Jun. 2023 (A$4.29 Mil).

Lumos Diagnostics Holdings Accounts Payable & Accrued Expense Historical Data

The historical data trend for Lumos Diagnostics Holdings's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumos Diagnostics Holdings Accounts Payable & Accrued Expense Chart

Lumos Diagnostics Holdings Annual Data

Trend

Jun22

Jun23

Accounts Payable & Accrued Expense

5.86

4.29

Lumos Diagnostics Holdings Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			3.53	5.86	6.11	4.29	3.06

Lumos Diagnostics Holdings Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Lumos Diagnostics Holdings (ASX:LDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumos Diagnostics Holdings Ltd (ASX:LDX) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

LDXHF:USA

Address

2724 Loker Ave West, Carlsbad, CA, USA, 92010

Website

https://www.lumosdiagnostics.com

Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. It also directly develops, manufactures and commercializes proprietary, Lumos-branded POC tests that target infectious and inflammatory diseases. It generates maximum revenue from the commercial services and solutions relating to POC diagnostic tests.

Lumos Diagnostics Holdings (ASX:LDX) Headlines

No Headlines